Related Articles

Kanaoka, Y., Ago, H., Inagaki, E., et al. Cloning and crystal structure of hematopoietic prostaglandin D synthase. Cell 90 1085-1095 (1997).

Zhang, J., Chung, T.D.Y., Oldenburg, K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. Journal of Biomolecular Screening 4(2) 67-73 (1999).

Pinzar, E., Miyano, M., Kanaoka, Y., et al. Structural basis of hematopoietic prostaglandin D synthase activity elucidated by site-directed mutagenesis. J Biol Chem 275(40) 31239-31244 (2000).

Inoue, T., Okano, Y., Kado, Y., et al. First determination of the inhibitor complex structure of human hematopoietic prostaglandin D synthase. J Biochem 135 279-283 (2004).

Aritake, K., Kado, Y., Inoue, T., et al. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem 281(22) 15277-15286 (2006).

Matsushita, K., Nobutoshi, A., Hizue, A. Pharmacological studies on the novel antiallergic drug HQL-79: I. Antiallergic and antiasthmatic effects in various experimental models. Jpn J Pharmacol 78(1) 1-10 (1998).

Matsushita, K., Nobutoshi, A., Aritake, K. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects. Jpn J Pharmacol 78(1) 11-22 (1998).

Hohwy, M., Spadola, L., Lundquist, B., et al. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design. J Med Chem 51 2178-2186 (2008).